Skip to main content

Table 5 Results of the main analysis

From: Is the concomitant use of clopidogrel and Proton Pump Inhibitors still associated with increased adverse cardiovascular outcomes following coronary angioplasty?: a systematic review and meta-analysis of recently published studies (2012 – 2016)

Outcomes analyzed

OR with 95% CI

P value

I2 (%)

Short term follow up

 Mortality

1.55 [1.43–1.68]

0.00001

0

 TVR

1.26 [1.06–1.49]

0.009

22

 MI

1.17 [0.86–1.58]

0.32

91

Long term follow up

 MACEs

1.37 [1.23–1.53]

0.00001

0

 MI

1.41 [1.26–1.57]

0.00001

29

 ST

1.38 [1.13–1.70]

0.002

0

 Mortality

1.26 [0.99–1.60]

0.06

61

 TVR

1.28 [1.01–1.61]

0.04

72

  1. Abbreviations: OR Odds ratio, CI Confidence interval, TVR Target vessel revascularization, MI Myocardial infarction, MACEs Major adverse cardiac events, ST Stent thrombosis